(-0.08%) 5 304.25 points
(-0.09%) 40 140 points
(-0.05%) 18 465 points
(-0.07%) $83.11
(-0.62%) $1.752
(0.73%) $2 254.80
(0.74%) $25.10
(0.21%) $923.00
(0.05%) $0.927
(0.29%) $10.87
(0.09%) $0.793
(-0.34%) $92.26
Live Chart Being Loaded With Signals
Walvax Biotechnology Co., Ltd., a biological pharmaceutical company, researches and develops, produces, and sells bio-medicine products in China. The company offers biomedicines, such as vaccines, blood products, and others...
Stats | |
---|---|
Today's Volume | 16.01M |
Average Volume | 18.17M |
Market Cap | 23.99B |
EPS | CNY0.0600 ( 2023-10-25 ) |
Last Dividend | CNY0 ( N/A ) |
Next Dividend | CNY0 ( N/A ) |
P/E | 33.43 |
ATR14 | CNY0.0180 (0.12%) |
Volume Correlation
Walvax Biotechnology Co., Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Walvax Biotechnology Co., Correlation - Currency/Commodity
Walvax Biotechnology Co., Financials
Annual | 2022 |
Revenue: | CNY5.09B |
Gross Profit: | CNY4.48B (88.02 %) |
EPS: | CNY0.450 |
Q3 | 2023 |
Revenue: | CNY990.37M |
Gross Profit: | CNY811.68M (81.96 %) |
EPS: | CNY0.0614 |
Q2 | 2023 |
Revenue: | CNY1.33B |
Gross Profit: | CNY1.19B (88.93 %) |
EPS: | CNY0.180 |
Q1 | 2023 |
Revenue: | CNY833.27M |
Gross Profit: | CNY708.42M (85.02 %) |
EPS: | CNY0.110 |
Financial Reports:
No articles found.
Walvax Biotechnology Co.,
Walvax Biotechnology Co., Ltd., a biological pharmaceutical company, researches and develops, produces, and sells bio-medicine products in China. The company offers biomedicines, such as vaccines, blood products, and others. It provides Group A, C meningococcal polysaccharide conjugate vaccine for infants below or equal to 2 years preventing diseases, such as cerebrospinal meningitis and septicemia; Group A and C meningococcal polysaccharide vaccine for in adults and children over the age of 2 years and adults to prevent disease caused by the bacterium Neisseria meningitidis group A or group C; and Group ACYW135 meningococcal polysaccharide vaccine for children above 2 years old to prevent epidemic cerebrospinal meningitis caused by Neisseria meningitidis group A, C, Y, and W135. The company also offers haemophilus influenzae type b conjugate vaccine for children from the age of 2 months to 5 years for the prevention of infectious diseases, including meningitis, pneumonia, septicemia, cellulitis, arthritis, epiglottitis, etc. In addition, it provides diphtheria, tetanus, and acellular pertussis combined vaccine for the prevention of diphtheria, tetanus, and pertussis for individuals from the age of 3 months to 6 years; and 23-valent pneumococcal polysaccharide vaccine for children above 2 years old to prevent pneumococcal disease caused by 23 serotypes. Walvax Biotechnology Co., Ltd. was founded in 2001 and is headquartered in Kunming, China.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators